Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

RotaTeq

Novartis building

Novartis’ Ultibro tops Seretide in comparative COPD trial

Will help Novartis position Ultibro as a corticosteroid-free alternative to GSK's blockbuster

dengue fever mosquito

Sanofi: positive trial sets up dengue vaccine filings

Could help prevent mosquito-borne fever that is endemic in Latin America and Asia

- PMLiVE

GSK Ebola vaccine to start safety studies

Will use volunteers in the US, UK and Africa

- PMLiVE

Rapid review for Pfizer’s superbug vaccine

FDA to expedite assessment of Clostridium difficile inoculation

- PMLiVE

ViiV bags US approval for HIV blockbuster-in-waiting

Drug combines antiretrovirals with Tivicay

- PMLiVE

Ex GSK exec to lead Sanford-Burnham

Perry Nisen appointed CEO at research institute

- PMLiVE

New York health department in HPV drive

New campaign will highlight the cancer-prevention benefits of the HPV vaccine

- PMLiVE

US panel backs pneumococcal vaccines for seniors

Vaccines to be provided by Merck & Co and Pfizer

- PMLiVE

GSK relaunches COPD website

Revamped online hub offers tools and guidance for those affected by respiratory condition

- PMLiVE

GSK investigator jailed by Chinese authorities

Peter Humphrey found guilty of breaking privacy laws

- PMLiVE

Pfizer closes on $1bn label expansion for Prevenar

EMA begins review of the pneumococcal vaccine

- PMLiVE

US fast-tracks Ebola vaccine trials as outbreak spreads

NIH brings forward human trials as concerns mount

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links